13-(2-Methylbenzyl) Berberine Is a More Potent Inhibitor of MexXY-Dependent Aminoglycoside Resistance than Berberine

We previously showed that berberine attenuates MexXY efflux-dependent aminoglycoside resistance in . Here, we aimed to synthesize berberine derivatives with higher MexXY inhibitory activities. We synthesized 11 berberine derivatives, of which 13-(2-methylbenzyl) berberine (13-o-MBB) but not its regi...

Full description

Saved in:
Bibliographic Details
Published inAntibiotics (Basel) Vol. 8; no. 4; p. 212
Main Authors Kotani, Kenta, Matsumura, Mio, Morita, Yuji, Tomida, Junko, Kutsuna, Ryo, Nishino, Kunihiko, Yasuike, Shuji, Kawamura, Yoshiaki
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 06.11.2019
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We previously showed that berberine attenuates MexXY efflux-dependent aminoglycoside resistance in . Here, we aimed to synthesize berberine derivatives with higher MexXY inhibitory activities. We synthesized 11 berberine derivatives, of which 13-(2-methylbenzyl) berberine (13-o-MBB) but not its regiomers showed the most promising MexXY inhibitory activity. 13-o-MBB reduced the minimum inhibitory concentrations (MICs) of various aminoglycosides 4- to 128 fold for a highly multidrug resistant strain. Moreover, 13-o-MBB significantly reduced the MICs of gentamicin and amikacin in and . The fractional inhibitory concentration indices indicated that 13-o-MBB acted synergistically with aminoglycosides in only MexXY-positive strains. Time-kill curves showed that 13-o-MBB or higher concentrations of berberine increased the bactericidal activity of gentamicin by inhibiting MexXY in . Our findings indicate that 13-o-MBB inhibits MexXY-dependent aminoglycoside drug resistance more strongly than berberine and that 13-o-MBB is a useful inhibitor of aminoglycoside drug resistance due to MexXY.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics8040212